MENLO PARK, Calif., Sept. 06, 2017 -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, September 27, 2017 at 8 a.m. Pacific time to discuss its results for the first quarter fiscal year 2018. Financial results will be reported for the 2018 fiscal first quarter ended August 27, 2017 after market close on September 26, 2017.
Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.
Date: Wednesday, September 27, 2017
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: (844) 860-6243
U.S. and International Toll Number: (661) 378-9884
Conference ID: 78782864
Webcast: http://ir.Landec.com/events.cfm
The webcast will be available for 30 days through October 27, 2017.
A replay of the teleconference will be available for one week until midnight Eastern time, Wednesday, October 4, 2017
Toll free replay dial in: (855) 859-2056
International replay: (404) 537-3406
Replay passcode: 78782864
About Landec Corporation
Landec Corporation (NASDAQ:LNDC) is a leading innovator of diversified health and wellness solutions within the packaged natural food and biomaterial markets. Apio, Landec's food business, is the leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Extending its reach into adjacent natural food products outside of produce, Landec recently acquired O Olive Oil, Inc., an organic and natural producer and marketer of olive oils and vinegars under the O brand. Lifecore Biomedical, Landec’s biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec’s website at www.landec.com.
CONTACT: Media and Industry Contact: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: ICR, Inc. John Mills, Partner (646) 277-1254 [email protected]


Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Bank of America's $72.5M Epstein Settlement: What You Need to Know
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Apple Turns 50: From Garage Startup to AI Crossroads
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth 



